Topamax Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Topamax: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_11298.JPG
Topamax 100mg Tab
Janssen Pharmaceuticals, Inc, fomerly Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals
Pill Identification: OMN,TOPAMAX  |  100

What is this Medicine?

TOPIRAMATE (toe PYRE a mate) is used to treat seizures in adults or children with epilepsy. It is also used for the prevention of migraine headaches.

CVS Pharmacy Patient Statistics for Topamax: Oral tablet(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Topamax 100mg Tablet

NDC: 504580641
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from moisture
Topamax 100mg Tablet
Drug Image file DrugItem_11298.JPG
Janssen Pharmaceuticals, Inc, fomerly Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals
Pill Identification: OMN,TOPAMAX  |  100
Shape: round
Color: yellow
Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Topamax

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.